The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Blue Eye Disease Vaccines Market Research Report 2024
Synopsis
PoRV causes a disease commonly referred to as “blue eye disease” because of the corneal opacity seen in some affected pigs
The global Blue Eye Disease Vaccines market was valued at US$ 157.5 million in 2023 and is anticipated to reach US$ 212.8 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The increasing prevalence of Blue Eye Disease, a viral infection affecting livestock, is driving the demand for vaccines. Factors such as rising awareness about animal health, government initiatives for disease control, and the growing livestock industry contribute to market expansion. Key players in the market are investing in research and development to develop effective and affordable vaccines. Additionally, advancements in biotechnology and vaccine manufacturing processes are expected to propel market growth. However, challenges such as stringent regulations and limited awareness in certain regions may hinder market growth. Overall, the Blue Eye Disease vaccines market is anticipated to witness substantial growth in the foreseeable future.
This report aims to provide a comprehensive presentation of the global market for Blue Eye Disease Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blue Eye Disease Vaccines.
Report Scope
The Blue Eye Disease Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blue Eye Disease Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blue Eye Disease Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CAHIC
Boehringer Ingelheim
MSD Animal Health
Chopper Biology
Ceva
Ringpu Biology
Qilu Animal
DHN
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Piglets
Adult Pigs
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Blue Eye Disease Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Blue Eye Disease Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
PoRV causes a disease commonly referred to as “blue eye disease” because of the corneal opacity seen in some affected pigs
The global Blue Eye Disease Vaccines market was valued at US$ 157.5 million in 2023 and is anticipated to reach US$ 212.8 million by 2030, witnessing a CAGR of 4.3% during the forecast period 2024-2030.
The increasing prevalence of Blue Eye Disease, a viral infection affecting livestock, is driving the demand for vaccines. Factors such as rising awareness about animal health, government initiatives for disease control, and the growing livestock industry contribute to market expansion. Key players in the market are investing in research and development to develop effective and affordable vaccines. Additionally, advancements in biotechnology and vaccine manufacturing processes are expected to propel market growth. However, challenges such as stringent regulations and limited awareness in certain regions may hinder market growth. Overall, the Blue Eye Disease vaccines market is anticipated to witness substantial growth in the foreseeable future.
This report aims to provide a comprehensive presentation of the global market for Blue Eye Disease Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blue Eye Disease Vaccines.
Report Scope
The Blue Eye Disease Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Blue Eye Disease Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Blue Eye Disease Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CAHIC
Boehringer Ingelheim
MSD Animal Health
Chopper Biology
Ceva
Ringpu Biology
Qilu Animal
DHN
Segment by Type
Live Vaccines
Killed Vaccines
Segment by Application
Piglets
Adult Pigs
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Blue Eye Disease Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Blue Eye Disease Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Blue Eye Disease Vaccines Market Overview
1.1 Product Overview and Scope of Blue Eye Disease Vaccines
1.2 Blue Eye Disease Vaccines Segment by Type
1.2.1 Global Blue Eye Disease Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Blue Eye Disease Vaccines Segment by Application
1.3.1 Global Blue Eye Disease Vaccines Market Value by Application: (2024-2030)
1.3.2 Piglets
1.3.3 Adult Pigs
1.4 Global Blue Eye Disease Vaccines Market Size Estimates and Forecasts
1.4.1 Global Blue Eye Disease Vaccines Revenue 2019-2030
1.4.2 Global Blue Eye Disease Vaccines Sales 2019-2030
1.4.3 Global Blue Eye Disease Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Blue Eye Disease Vaccines Market Competition by Manufacturers
2.1 Global Blue Eye Disease Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Blue Eye Disease Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Blue Eye Disease Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Blue Eye Disease Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Blue Eye Disease Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Blue Eye Disease Vaccines, Product Type & Application
2.7 Blue Eye Disease Vaccines Market Competitive Situation and Trends
2.7.1 Blue Eye Disease Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Blue Eye Disease Vaccines Players Market Share by Revenue
2.7.3 Global Blue Eye Disease Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Blue Eye Disease Vaccines Retrospective Market Scenario by Region
3.1 Global Blue Eye Disease Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Blue Eye Disease Vaccines Global Blue Eye Disease Vaccines Sales by Region: 2019-2030
3.2.1 Global Blue Eye Disease Vaccines Sales by Region: 2019-2024
3.2.2 Global Blue Eye Disease Vaccines Sales by Region: 2025-2030
3.3 Global Blue Eye Disease Vaccines Global Blue Eye Disease Vaccines Revenue by Region: 2019-2030
3.3.1 Global Blue Eye Disease Vaccines Revenue by Region: 2019-2024
3.3.2 Global Blue Eye Disease Vaccines Revenue by Region: 2025-2030
3.4 North America Blue Eye Disease Vaccines Market Facts & Figures by Country
3.4.1 North America Blue Eye Disease Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Blue Eye Disease Vaccines Sales by Country (2019-2030)
3.4.3 North America Blue Eye Disease Vaccines Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Blue Eye Disease Vaccines Market Facts & Figures by Country
3.5.1 Europe Blue Eye Disease Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Blue Eye Disease Vaccines Sales by Country (2019-2030)
3.5.3 Europe Blue Eye Disease Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Blue Eye Disease Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Blue Eye Disease Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Blue Eye Disease Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Blue Eye Disease Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Blue Eye Disease Vaccines Market Facts & Figures by Country
3.7.1 Latin America Blue Eye Disease Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Blue Eye Disease Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Blue Eye Disease Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Blue Eye Disease Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Blue Eye Disease Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Blue Eye Disease Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Blue Eye Disease Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Blue Eye Disease Vaccines Sales by Type (2019-2030)
4.1.1 Global Blue Eye Disease Vaccines Sales by Type (2019-2024)
4.1.2 Global Blue Eye Disease Vaccines Sales by Type (2025-2030)
4.1.3 Global Blue Eye Disease Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Blue Eye Disease Vaccines Revenue by Type (2019-2030)
4.2.1 Global Blue Eye Disease Vaccines Revenue by Type (2019-2024)
4.2.2 Global Blue Eye Disease Vaccines Revenue by Type (2025-2030)
4.2.3 Global Blue Eye Disease Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Blue Eye Disease Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Blue Eye Disease Vaccines Sales by Application (2019-2030)
5.1.1 Global Blue Eye Disease Vaccines Sales by Application (2019-2024)
5.1.2 Global Blue Eye Disease Vaccines Sales by Application (2025-2030)
5.1.3 Global Blue Eye Disease Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Blue Eye Disease Vaccines Revenue by Application (2019-2030)
5.2.1 Global Blue Eye Disease Vaccines Revenue by Application (2019-2024)
5.2.2 Global Blue Eye Disease Vaccines Revenue by Application (2025-2030)
5.2.3 Global Blue Eye Disease Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Blue Eye Disease Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CAHIC
6.1.1 CAHIC Corporation Information
6.1.2 CAHIC Description and Business Overview
6.1.3 CAHIC Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CAHIC Blue Eye Disease Vaccines Product Portfolio
6.1.5 CAHIC Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Boehringer Ingelheim Blue Eye Disease Vaccines Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 MSD Animal Health
6.3.1 MSD Animal Health Corporation Information
6.3.2 MSD Animal Health Description and Business Overview
6.3.3 MSD Animal Health Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 MSD Animal Health Blue Eye Disease Vaccines Product Portfolio
6.3.5 MSD Animal Health Recent Developments/Updates
6.4 Chopper Biology
6.4.1 Chopper Biology Corporation Information
6.4.2 Chopper Biology Description and Business Overview
6.4.3 Chopper Biology Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chopper Biology Blue Eye Disease Vaccines Product Portfolio
6.4.5 Chopper Biology Recent Developments/Updates
6.5 Ceva
6.5.1 Ceva Corporation Information
6.5.2 Ceva Description and Business Overview
6.5.3 Ceva Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ceva Blue Eye Disease Vaccines Product Portfolio
6.5.5 Ceva Recent Developments/Updates
6.6 Ringpu Biology
6.6.1 Ringpu Biology Corporation Information
6.6.2 Ringpu Biology Description and Business Overview
6.6.3 Ringpu Biology Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ringpu Biology Blue Eye Disease Vaccines Product Portfolio
6.6.5 Ringpu Biology Recent Developments/Updates
6.7 Qilu Animal
6.6.1 Qilu Animal Corporation Information
6.6.2 Qilu Animal Description and Business Overview
6.6.3 Qilu Animal Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Qilu Animal Blue Eye Disease Vaccines Product Portfolio
6.7.5 Qilu Animal Recent Developments/Updates
6.8 DHN
6.8.1 DHN Corporation Information
6.8.2 DHN Description and Business Overview
6.8.3 DHN Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 DHN Blue Eye Disease Vaccines Product Portfolio
6.8.5 DHN Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Blue Eye Disease Vaccines Industry Chain Analysis
7.2 Blue Eye Disease Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Blue Eye Disease Vaccines Production Mode & Process
7.4 Blue Eye Disease Vaccines Sales and Marketing
7.4.1 Blue Eye Disease Vaccines Sales Channels
7.4.2 Blue Eye Disease Vaccines Distributors
7.5 Blue Eye Disease Vaccines Customers
8 Blue Eye Disease Vaccines Market Dynamics
8.1 Blue Eye Disease Vaccines Industry Trends
8.2 Blue Eye Disease Vaccines Market Drivers
8.3 Blue Eye Disease Vaccines Market Challenges
8.4 Blue Eye Disease Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
